| 000 | 01477 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512075407.0 | ||
| 264 | 0 | _c19850503 | |
| 008 | 198505s 0 0 ger d | ||
| 022 | _a0378-584X | ||
| 024 | 7 |
_a10.1159/000215606 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNowrousian, M R | |
| 245 | 0 | 0 |
_a[High-dose cytarabine treatment in acute leukemias and leukemic meningiosis: clinical aspects and pharmacokinetics]. _h[electronic resource] |
| 260 |
_bOnkologie _cFeb 1985 |
||
| 300 |
_a26-32 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBone Marrow _xdrug effects |
| 650 | 0 | 4 |
_aCytarabine _xadverse effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aLeukemia _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aLeukemia, Lymphoid _xdrug therapy |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeningeal Neoplasms _xcerebrospinal fluid |
| 650 | 0 | 4 | _aMiddle Aged |
| 700 | 1 | _aSeeber, S | |
| 700 | 1 | _aMiller, A A | |
| 700 | 1 | _aAnders, C | |
| 700 | 1 | _aOhl, S | |
| 700 | 1 | _aSchmidt, C G | |
| 773 | 0 |
_tOnkologie _gvol. 8 _gno. 1 _gp. 26-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000215606 _zAvailable from publisher's website |
| 999 |
_c3890807 _d3890807 |
||